| Product Type | Impurity Standards |
| CAT. No. | MRL-S06001 |
| CAS. No. | 405-85-6 |
| Mol. Formula | C14H11FO3 |
| Mol. Weight | 246.24 |
| Synonyms | NA |
| Chemical Name | 4-((3-Fluorobenzyl)oxy)benzoic acid |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Safinamide Impurity 9 with CAS No: 405-85-6 is an impurity standard of Safinamide. Safinamide, a monoamine oxidase B (MAO-B) inhibitor, is utilized as an adjunct to levodopa/carbidopa therapy for Parkinsons disease. By selectively inhibiting MAO-B, the enzyme responsible for dopamine breakdown in the brain, safinamide increases dopamine levels, improving motor function and alleviating symptoms of Parkinsons. Additionally, its unique non-dopaminergic effects, such as sodium channel blockade, contribute to its antiparkinsonian properties. Generally well-tolerated, safinamide represents a valuable treatment option, though careful monitoring for potential interactions is essential for optimal therapeutic outcomes in individuals with Parkinsons disease. Buy high quality Safinamide Impurity 9 from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Safinamide Impurity 9